MeVP29 (R), n=1 cell(s)

Main group: Visual Projection Neurons; Neurotransmitter consensus prediction: ACh

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - 5.0 2.0 9.0 607.0 2069.0 428.0 40.0 - 3160
1 - - - - - 13.0 359.0 14.0 - - 386
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - - - -
Pre - - - - - - - -
  AME
0 170
1 1
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 705
1 1071

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:3160
Number of pre synapses:386
Number of output connections:904
Coverage factor:1.0
Columnar completeness:0.67
Area completeness:0.92
Cell size (columns):594

Lobula

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#MeVP29 (R) % % cumu.
0 Cm6 (R) GABA 640 640.0 18.9% 18.9%
1 Cm3 (R) GABA 345 345.0 10.2% 29.1%
2 MeLo6 (R) ACh 287 287.0 8.5% 37.6%
3 Cm8 (R) GABA 225 225.0 6.6% 44.2%
4 Cm31b (R) GABA 119 119.0 3.5% 47.7%
5 MeVPMe4 (L) Glu 108 108.0 3.2% 50.9%
6 Tm39 (R) ACh 81 81.0 2.4% 53.3%
7 MeTu4c (R) ACh 75 75.0 2.2% 55.5%
8 Tm5Y (R) ACh 71 71.0 2.1% 57.6%
9 MeVP6 (R) Glu 61 61.0 1.8% 59.4%
10 MeLo7 (R) ACh 56 56.0 1.7% 61.1%
11 MeVC2 (L) ACh 46 46.0 1.4% 62.5%
12 Tm4 (R) ACh 45 45.0 1.3% 63.8%
13 TmY21 (R) ACh 42 42.0 1.2% 65.0%
14 MeLo3b (R) ACh 39 39.0 1.2% 66.2%
15 OLVC5 (R) ACh 38 38.0 1.1% 67.3%
16 Tm37 (R) Glu 38 38.0 1.1% 68.4%
17 aMe6b (R) ACh 37 37.0 1.1% 69.5%
18 Tm16 (R) ACh 36 36.0 1.1% 70.6%
19 MeVP62 (R) ACh 35 35.0 1.0% 71.6%
20 MeLo1 (R) ACh 32 32.0 0.9% 72.6%
21 Mi17 (R) GABA 31 31.0 0.9% 73.5%
22 TmY10 (R) ACh 31 31.0 0.9% 74.4%
23 MeTu4a (R) ACh 30 30.0 0.9% 75.3%
24 MeVPMe6 (L) Glu 28 28.0 0.8% 76.1%
25 MeVPMe11 (L) Glu 26 26.0 0.8% 76.9%
26 MeLo3a (R) ACh 23 23.0 0.7% 77.5%
27 MeVP11 (R) ACh 23 23.0 0.7% 78.2%
28 MeVPaMe2 (L) Glu 23 23.0 0.7% 78.9%
29 MeLo4 (R) ACh 22 22.0 0.6% 79.6%
30 aMe22 (R) Glu 20 20.0 0.6% 80.1%
31 MeTu3c (R) ACh 20 20.0 0.6% 80.7%
32 Cm30 (R) GABA 19 19.0 0.6% 81.3%
33 Mi15 (R) ACh 19 19.0 0.6% 81.9%
34 MeVP14 (R) ACh 18 18.0 0.5% 82.4%
35 MeVP38 (R) ACh 18 18.0 0.5% 82.9%
36 Cm4 (R) Glu 17 17.0 0.5% 83.4%
37 MeVC20 (R) Glu 17 17.0 0.5% 83.9%
38 Tm20 (R) ACh 17 17.0 0.5% 84.4%
39 MeVPMe3 (L) Glu 16 16.0 0.5% 84.9%
40 MeVC27 (L) unclear 15 15.0 0.4% 85.3%
41 MeVC4a (L) ACh 15 15.0 0.4% 85.8%
42 Tm34 (R) Glu 14 14.0 0.4% 86.2%
43 aMe2 (R) Glu 13 13.0 0.4% 86.6%
44 Mi4 (R) GABA 13 13.0 0.4% 87.0%
45 Tm36 (R) ACh 13 13.0 0.4% 87.4%
46 TmY17 (R) ACh 13 13.0 0.4% 87.7%
47 MeVPMe10 (L) Glu 12 12.0 0.4% 88.1%
48 MeVPMe5 (L) Glu 12 12.0 0.4% 88.4%
49 Tm40 (R) ACh 12 12.0 0.4% 88.8%
50 Cm12 (R) GABA 11 11.0 0.3% 89.1%
51 Cm20 (R) GABA 11 11.0 0.3% 89.5%
52 Cm7 (R) Glu 11 11.0 0.3% 89.8%
53 Dm8b (R) Glu 11 11.0 0.3% 90.1%
54 DNpe053 (R) ACh 11 11.0 0.3% 90.4%
55 MeVC9 (L) ACh 11 11.0 0.3% 90.8%
56 aMe6c (R) Glu 10 10.0 0.3% 91.0%
57 aMe9 (R) ACh 10 10.0 0.3% 91.3%
58 Cm9 (R) Glu 10 10.0 0.3% 91.6%
59 Dm2 (R) ACh 9 9.0 0.3% 91.9%
60 DNpe053 (L) ACh 9 9.0 0.3% 92.2%
61 MeLo5 (R) ACh 9 9.0 0.3% 92.4%
62 MeVP2 (R) ACh 9 9.0 0.3% 92.7%
63 MeVP32 (R) ACh 9 9.0 0.3% 93.0%
64 OA-AL2i4 (R) OA 9 9.0 0.3% 93.2%
65 Tm38 (R) ACh 9 9.0 0.3% 93.5%
66 MeTu1 (R) ACh 7 7.0 0.2% 93.7%
67 MeTu4f (R) ACh 7 7.0 0.2% 93.9%
68 MeVP15 (R) ACh 7 7.0 0.2% 94.1%
69 aMe25 (R) unclear 6 6.0 0.2% 94.3%
70 Cm29 (R) GABA 6 6.0 0.2% 94.5%
71 Cm5 (R) GABA 6 6.0 0.2% 94.7%
72 ME_unclear (R) ACh 6 6.0 0.2% 94.8%
73 MeVC3 (L) ACh 6 6.0 0.2% 95.0%
74 TmY13 (R) ACh 6 6.0 0.2% 95.2%
75 Dm8a (R) Glu 5 5.0 0.1% 95.3%
76 MeVC5 (L) ACh 5 5.0 0.1% 95.5%
77 MeVP4 (R) ACh 5 5.0 0.1% 95.6%
78 aMe5 (R) ACh 4 4.0 0.1% 95.7%
79 aMe9 (L) ACh 4 4.0 0.1% 95.9%
80 Cm17 (R) GABA 4 4.0 0.1% 96.0%
81 LoVP96 (R) Glu 4 4.0 0.1% 96.1%
82 MeVPaMe1 (L) ACh 4 4.0 0.1% 96.2%
83 Mi18 (R) GABA 4 4.0 0.1% 96.3%
84 Tm31 (R) Glu 4 4.0 0.1% 96.5%
85 Y3 (R) ACh 4 4.0 0.1% 96.6%
86 Cm10 (R) GABA 3 3.0 0.1% 96.7%
87 MeLo8 (R) GABA 3 3.0 0.1% 96.8%
88 MeVC10 (L) ACh 3 3.0 0.1% 96.8%
89 MeVPOL1 (R) ACh 3 3.0 0.1% 96.9%
90 Pm12 (R) Glu 3 3.0 0.1% 97.0%
91 Tm26 (R) ACh 3 3.0 0.1% 97.1%
92 Tm5b (R) ACh 3 3.0 0.1% 97.2%
93 Tm5c (R) Glu 3 3.0 0.1% 97.3%
94 Tm6 (R) ACh 3 3.0 0.1% 97.4%
95 5-HTPMPV03 (L) 5HT 2 2.0 0.1% 97.4%
96 aMe15 (R) unclear 2 2.0 0.1% 97.5%
97 aMe17b (R) GABA 2 2.0 0.1% 97.5%
98 aMe30 (R) Glu 2 2.0 0.1% 97.6%
99 Cm15 (R) GABA 2 2.0 0.1% 97.7%
100 Cm27 (R) Glu 2 2.0 0.1% 97.7%
101 Cm34 (R) Glu 2 2.0 0.1% 97.8%
102 Dm-DRA1 (R) Glu 2 2.0 0.1% 97.8%
103 Dm12 (R) Glu 2 2.0 0.1% 97.9%
104 LC14b (L) ACh 2 2.0 0.1% 98.0%
105 MeLo2 (R) ACh 2 2.0 0.1% 98.0%
106 MeTu3b (R) ACh 2 2.0 0.1% 98.1%
107 MeTu4b (R) ACh 2 2.0 0.1% 98.1%
108 MeVC4b (L) ACh 2 2.0 0.1% 98.2%
109 MeVC7a (L) ACh 2 2.0 0.1% 98.3%
110 MeVP49 (R) unclear 2 2.0 0.1% 98.3%
111 MeVP5 (R) unclear 2 2.0 0.1% 98.4%
112 MeVPMe12 (R) ACh 2 2.0 0.1% 98.4%
113 Mi16 (R) GABA 2 2.0 0.1% 98.5%
114 Pm4 (R) GABA 2 2.0 0.1% 98.6%
115 T2a (R) ACh 2 2.0 0.1% 98.6%
116 Tm12 (R) ACh 2 2.0 0.1% 98.7%
117 Tm32 (R) Glu 2 2.0 0.1% 98.7%
118 TmY18 (R) ACh 2 2.0 0.1% 98.8%
119 TmY5a (R) Glu 2 2.0 0.1% 98.8%
120 aMe1 (R) GABA 1 1.0 0.0% 98.9%
121 aMe10 (R) ACh 1 1.0 0.0% 98.9%
122 aMe3 (R) Glu 1 1.0 0.0% 98.9%
123 aMe4 (R) ACh 1 1.0 0.0% 99.0%
124 Cm13 (R) Glu 1 1.0 0.0% 99.0%
125 Cm16 (R) Glu 1 1.0 0.0% 99.0%
126 Cm24 (R) Glu 1 1.0 0.0% 99.1%
127 Cm25 (R) Glu 1 1.0 0.0% 99.1%
128 Cm26 (R) Glu 1 1.0 0.0% 99.1%
129 Cm33 (R) GABA 1 1.0 0.0% 99.1%
130 Lat3 (R) unclear 1 1.0 0.0% 99.2%
131 Lawf2 (R) ACh 1 1.0 0.0% 99.2%
132 LT58 (R) Glu 1 1.0 0.0% 99.2%
133 MeLo13 (R) Glu 1 1.0 0.0% 99.3%
134 MeVC11 (L) ACh 1 1.0 0.0% 99.3%
135 MeVC21 (R) Glu 1 1.0 0.0% 99.3%
136 MeVP1 (R) ACh 1 1.0 0.0% 99.4%
137 MeVP10 (R) ACh 1 1.0 0.0% 99.4%
138 MeVP12 (R) ACh 1 1.0 0.0% 99.4%
139 MeVP16 (R) Glu 1 1.0 0.0% 99.4%
140 MeVP21 (R) ACh 1 1.0 0.0% 99.5%
141 MeVP3 (R) ACh 1 1.0 0.0% 99.5%
142 MeVP30 (R) ACh 1 1.0 0.0% 99.5%
143 MeVP33 (R) ACh 1 1.0 0.0% 99.6%
144 MeVP45 (R) ACh 1 1.0 0.0% 99.6%
145 MeVP6_unclear (R) Glu 1 1.0 0.0% 99.6%
146 MeVPaMe1 (R) ACh 1 1.0 0.0% 99.6%
147 MeVPLo2 (R) ACh 1 1.0 0.0% 99.7%
148 MeVPMe1 (R) Glu 1 1.0 0.0% 99.7%
149 MeVPMe9 (R) Glu 1 1.0 0.0% 99.7%
150 Mi9 (R) Glu 1 1.0 0.0% 99.8%
151 OA-AL2i3 (R) OA 1 1.0 0.0% 99.8%
152 OA-ASM1 (R) OA 1 1.0 0.0% 99.8%
153 OA-ASM1 (L) OA 1 1.0 0.0% 99.9%
154 OCG02c (R) unclear 1 1.0 0.0% 99.9%
155 OLVC4 (L) unclear 1 1.0 0.0% 99.9%
156 Tm3 (R) ACh 1 1.0 0.0% 99.9%
157 Tm33 (R) ACh 1 1.0 0.0% 100.0%
158 Y13 (R) Glu 1 1.0 0.0% 100.0%

Outputs

  instance NT total connections connections /#MeVP29 (R) % % cumu.
0 Cm7 (R) Glu 125 125.0 10.0% 10.0%
1 Cm24 (R) Glu 88 88.0 7.0% 17.0%
2 MeVP62 (R) ACh 75 75.0 6.0% 23.0%
3 Tm34 (R) Glu 64 64.0 5.1% 28.1%
4 TmY17 (R) ACh 47 47.0 3.7% 31.8%
5 LoVP96 (R) Glu 42 42.0 3.3% 35.2%
6 MeVC20 (R) Glu 41 41.0 3.3% 38.4%
7 Cm9 (R) Glu 34 34.0 2.7% 41.1%
8 Tm32 (R) Glu 33 33.0 2.6% 43.8%
9 MeTu4c (R) ACh 27 27.0 2.2% 45.9%
10 TmY10 (R) ACh 27 27.0 2.2% 48.1%
11 aMe17a (R) Glu 26 26.0 2.1% 50.2%
12 LT88 (R) Glu 20 20.0 1.6% 51.8%
13 MeLo6 (R) ACh 20 20.0 1.6% 53.3%
14 MeVP14 (R) ACh 19 19.0 1.5% 54.9%
15 Tm36 (R) ACh 19 19.0 1.5% 56.4%
16 LoVP38 (R) Glu 18 18.0 1.4% 57.8%
17 Cm27 (R) Glu 17 17.0 1.4% 59.2%
18 MeVP58 (R) unclear 17 17.0 1.4% 60.5%
19 MeVP6 (R) Glu 17 17.0 1.4% 61.9%
20 aMe20 (R) unclear 16 16.0 1.3% 63.2%
21 OA-AL2i4 (R) OA 16 16.0 1.3% 64.4%
22 Tm37 (R) Glu 16 16.0 1.3% 65.7%
23 MeVC22 (R) Glu 15 15.0 1.2% 66.9%
24 aMe17e (R) Glu 14 14.0 1.1% 68.0%
25 DNpe021 (R) unclear 14 14.0 1.1% 69.1%
26 aMe8 (R) ACh 13 13.0 1.0% 70.2%
27 Pm13 (R) Glu 13 13.0 1.0% 71.2%
28 Cm3 (R) GABA 12 12.0 1.0% 72.2%
29 FB8B (R) unclear 12 12.0 1.0% 73.1%
30 MeVC21 (R) Glu 12 12.0 1.0% 74.1%
31 PLP211 (R) unclear 12 12.0 1.0% 75.0%
32 Mi16 (R) GABA 11 11.0 0.9% 75.9%
33 CL063 (R) unclear 9 9.0 0.7% 76.6%
34 LoVP50 (R) ACh 9 9.0 0.7% 77.4%
35 LoVP53 (R) ACh 9 9.0 0.7% 78.1%
36 MeVC24 (R) Glu 9 9.0 0.7% 78.8%
37 aMe17c (R) Glu 8 8.0 0.6% 79.4%
38 Cm8 (R) GABA 8 8.0 0.6% 80.1%
39 MeVC23 (R) Glu 8 8.0 0.6% 80.7%
40 aMe15 (R) unclear 7 7.0 0.6% 81.3%
41 MeVPaMe1 (R) ACh 7 7.0 0.6% 81.8%
42 aMe_TBD1 (R) unclear 6 6.0 0.5% 82.3%
43 Cm6 (R) GABA 6 6.0 0.5% 82.8%
44 MeLo4 (R) ACh 6 6.0 0.5% 83.3%
45 Pm8 (R) GABA 6 6.0 0.5% 83.7%
46 Tm16 (R) ACh 6 6.0 0.5% 84.2%
47 Tm5c (R) Glu 6 6.0 0.5% 84.7%
48 TmY21 (R) ACh 6 6.0 0.5% 85.2%
49 Cm15 (R) GABA 5 5.0 0.4% 85.6%
50 Cm16 (R) Glu 5 5.0 0.4% 86.0%
51 MeTu4e (R) ACh 5 5.0 0.4% 86.4%
52 PLP094 (R) unclear 5 5.0 0.4% 86.8%
53 SMP200 (R) unclear 5 5.0 0.4% 87.2%
54 WED094a (R) unclear 5 5.0 0.4% 87.6%
55 aMe30 (R) Glu 4 4.0 0.3% 87.9%
56 aMe9 (R) ACh 4 4.0 0.3% 88.2%
57 Cm20 (R) GABA 4 4.0 0.3% 88.5%
58 Cm5 (R) GABA 4 4.0 0.3% 88.8%
59 LPLC1 (R) ACh 4 4.0 0.3% 89.2%
60 MeVP46 (R) Glu 4 4.0 0.3% 89.5%
61 Pm12 (R) Glu 4 4.0 0.3% 89.8%
62 Tm29 (R) Glu 4 4.0 0.3% 90.1%
63 aMe2 (R) Glu 3 3.0 0.2% 90.4%
64 aMe5 (R) ACh 3 3.0 0.2% 90.6%
65 Cm13 (R) Glu 3 3.0 0.2% 90.8%
66 MeLo1 (R) ACh 3 3.0 0.2% 91.1%
67 MeLo5 (R) ACh 3 3.0 0.2% 91.3%
68 MeTu4f (R) ACh 3 3.0 0.2% 91.5%
69 MeVC_unclear (R) Glu 3 3.0 0.2% 91.8%
70 MeVP38 (R) ACh 3 3.0 0.2% 92.0%
71 MeVPMe4 (R) Glu 3 3.0 0.2% 92.3%
72 Mi17 (R) GABA 3 3.0 0.2% 92.5%
73 PS058 (R) unclear 3 3.0 0.2% 92.7%
74 Tm38 (R) ACh 3 3.0 0.2% 93.0%
75 Cm12 (R) GABA 2 2.0 0.2% 93.1%
76 Cm28 (R) unclear 2 2.0 0.2% 93.3%
77 Cm30 (R) GABA 2 2.0 0.2% 93.5%
78 Cm31a (R) GABA 2 2.0 0.2% 93.6%
79 Cm34 (R) Glu 2 2.0 0.2% 93.8%
80 Lawf2 (R) ACh 2 2.0 0.2% 93.9%
81 LT58 (R) Glu 2 2.0 0.2% 94.1%
82 MeLo3b (R) ACh 2 2.0 0.2% 94.3%
83 MeLo7 (R) ACh 2 2.0 0.2% 94.4%
84 MeTu4a (R) ACh 2 2.0 0.2% 94.6%
85 MeVC11 (L) ACh 2 2.0 0.2% 94.7%
86 MeVP10 (R) ACh 2 2.0 0.2% 94.9%
87 MeVP11 (R) ACh 2 2.0 0.2% 95.1%
88 MeVP2 (R) ACh 2 2.0 0.2% 95.2%
89 MeVP25 (R) unclear 2 2.0 0.2% 95.4%
90 MeVP33 (R) ACh 2 2.0 0.2% 95.5%
91 MeVP6_unclear (R) Glu 2 2.0 0.2% 95.7%
92 MeVPMe4 (L) Glu 2 2.0 0.2% 95.9%
93 OA-ASM1 (L) OA 2 2.0 0.2% 96.0%
94 SMP217 (R) unclear 2 2.0 0.2% 96.2%
95 Tm26 (R) ACh 2 2.0 0.2% 96.3%
96 Tm5Y (R) ACh 2 2.0 0.2% 96.5%
97 5-HTPMPV01 (L) unclear 1 1.0 0.1% 96.6%
98 5-HTPMPV03 (R) 5HT 1 1.0 0.1% 96.7%
99 aMe26 (R) ACh 1 1.0 0.1% 96.7%
100 Cm17 (R) GABA 1 1.0 0.1% 96.8%
101 Cm25 (R) Glu 1 1.0 0.1% 96.9%
102 Cm31b (R) GABA 1 1.0 0.1% 97.0%
103 Cm4 (R) Glu 1 1.0 0.1% 97.0%
104 DNp27 (R) unclear 1 1.0 0.1% 97.1%
105 Lat1 (R) unclear 1 1.0 0.1% 97.2%
106 Lat3 (R) unclear 1 1.0 0.1% 97.3%
107 Li20 (R) Glu 1 1.0 0.1% 97.4%
108 LoVP73 (R) unclear 1 1.0 0.1% 97.4%
109 LPi34 (R) Glu 1 1.0 0.1% 97.5%
110 LPT51 (R) Glu 1 1.0 0.1% 97.6%
111 LPT54 (R) ACh 1 1.0 0.1% 97.7%
112 MeTu4b (R) ACh 1 1.0 0.1% 97.8%
113 MeVC2 (L) ACh 1 1.0 0.1% 97.8%
114 MeVC3 (L) ACh 1 1.0 0.1% 97.9%
115 MeVC4b (L) ACh 1 1.0 0.1% 98.0%
116 MeVC5 (L) ACh 1 1.0 0.1% 98.1%
117 MeVP18 (R) unclear 1 1.0 0.1% 98.2%
118 MeVP39 (R) unclear 1 1.0 0.1% 98.2%
119 MeVP40 (R) unclear 1 1.0 0.1% 98.3%
120 MeVP45 (R) ACh 1 1.0 0.1% 98.4%
121 MeVP61 (R) unclear 1 1.0 0.1% 98.5%
122 MeVPMe1 (L) Glu 1 1.0 0.1% 98.6%
123 MeVPMe2 (L) Glu 1 1.0 0.1% 98.6%
124 MeVPMe2 (R) Glu 1 1.0 0.1% 98.7%
125 MeVPMe9 (R) Glu 1 1.0 0.1% 98.8%
126 Mi10 (R) ACh 1 1.0 0.1% 98.9%
127 Mi18 (R) GABA 1 1.0 0.1% 99.0%
128 Mi19 (R) 5HT 1 1.0 0.1% 99.0%
129 Mi4 (R) GABA 1 1.0 0.1% 99.1%
130 OLVC5 (R) ACh 1 1.0 0.1% 99.2%
131 PLP004 (R) unclear 1 1.0 0.1% 99.3%
132 Pm4 (R) GABA 1 1.0 0.1% 99.4%
133 SLP250 (R) unclear 1 1.0 0.1% 99.4%
134 T2a (R) ACh 1 1.0 0.1% 99.5%
135 Tm31 (R) Glu 1 1.0 0.1% 99.6%
136 Tm35 (R) Glu 1 1.0 0.1% 99.7%
137 Tm40 (R) ACh 1 1.0 0.1% 99.8%
138 Tm6 (R) ACh 1 1.0 0.1% 99.8%
139 TmY13 (R) ACh 1 1.0 0.1% 99.9%
140 TmY5a (R) Glu 1 1.0 0.1% 100.0%